why choose us

First received: June 17, 2024

Clinical Trial: Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Germ Cell Tumor

Study Type: INTERVENTIONAL


Official Title: Clinical Study of Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor in Children

Brief Summary: Remarkable progress has been made in treating germ-cell tumor (GCT) through the use of platinum-based regimens.However, part of yolk sac tumor (YST) with cisplatin resistance or recurrence is nevertheless prone to relapse after second-line treatment.This leaves a gap in effective treatment, which needs to be filled by novel therapeutic approaches.This paper is the first one to report the treatment combining thalidomide with nab-paclitaxel, gemcitabine, and epirubicin (T-TGA) for children with repeated relapsed or…

Read more